Suppression of the hypothalamic–pituitary–gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: Studies in human GnRH receptor knock-in mice
2014 ◽
Vol 723
◽
pp. 167-174
◽
Keyword(s):
2006 ◽
Vol 49
(11)
◽
pp. 3362-3367
◽
Keyword(s):
2006 ◽
Vol 49
(19)
◽
pp. 5849-5849
◽
Keyword(s):
2003 ◽
Vol 305
(2)
◽
pp. 688-695
◽
2009 ◽
Vol 19
(7)
◽
pp. 1986-1990
◽
2002 ◽
Vol 12
(23)
◽
pp. 3467-3470
◽
Keyword(s):